| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1–infected cells
|
Ikebe, Emi
|
|
|
4 |
9 |
p. 1845-1858
|
artikel
|
| 2 |
Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results
|
Gardin, Claude
|
|
|
4 |
9 |
p. 1942-1949
|
artikel
|
| 3 |
Adult T-cell leukemia/lymphoma incidence rate in French Guiana: a prospective cohort of women infected with HTLV-1
|
Ramassamy, Jill-Léa
|
|
|
4 |
9 |
p. 2044-2048
|
artikel
|
| 4 |
A user guide to the American Society of Hematology clinical practice guidelines
|
Izcovich, Ariel
|
|
|
4 |
9 |
p. 2095-2110
|
artikel
|
| 5 |
Bai X, Huang L, Niu L, et al. Mst1 positively regulates B-cell receptor signaling via CD19 transcriptional levels. Blood Adv. 2016;1(3):219-230.
|
|
|
|
4 |
9 |
p. 1844
|
artikel
|
| 6 |
BK virus–specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation
|
Espada, Eduardo
|
|
|
4 |
9 |
p. 1881-1893
|
artikel
|
| 7 |
Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease
|
Srisuwananukorn, Andrew
|
|
|
4 |
9 |
p. 1978-1986
|
artikel
|
| 8 |
Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation
|
Al Malki, Monzr M.
|
|
|
4 |
9 |
p. 2073-2083
|
artikel
|
| 9 |
Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes
|
Lin, Kimberly
|
|
|
4 |
9 |
p. 2049-2057
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
4 |
9 |
p. i
|
artikel
|
| 11 |
Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity
|
Payen, Mathilde
|
|
|
4 |
9 |
p. 1824-1832
|
artikel
|
| 12 |
FVIII half-life extension by coadministration of a D′D3 albumin fusion protein in mice, rabbits, rats, and monkeys
|
Pestel, Sabine
|
|
|
4 |
9 |
p. 1870-1880
|
artikel
|
| 13 |
Huang L, Sun X, Yang D, et al. WASP and Mst1 coregulate B-cell development and B-cell receptor signaling. Blood Adv. 2020;4(3):573-585.
|
|
|
|
4 |
9 |
p. 1916
|
artikel
|
| 14 |
Inducible MyD88/CD40 synergizes with IL-15 to enhance antitumor efficacy of CAR-NK cells
|
Wang, Xiaomei
|
|
|
4 |
9 |
p. 1950-1964
|
artikel
|
| 15 |
Induction of blood-circulating bile acids supports recovery from myelosuppressive chemotherapy
|
Sigurdsson, Valgardur
|
|
|
4 |
9 |
p. 1833-1843
|
artikel
|
| 16 |
Inflammatory signaling in dengue-infected platelets requires translation and secretion of nonstructural protein 1
|
Quirino-Teixeira, Anna Cecíllia
|
|
|
4 |
9 |
p. 2018-2031
|
artikel
|
| 17 |
Laboratory monitoring of hemophilia A treatments: new challenges
|
Lenting, Peter J.
|
|
|
4 |
9 |
p. 2111-2118
|
artikel
|
| 18 |
Maternal microchimerism protects hemophilia A patients from inhibitor development
|
Lu, Yeling
|
|
|
4 |
9 |
p. 1867-1869
|
artikel
|
| 19 |
Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match
|
Giri, Jayeeta
|
|
|
4 |
9 |
p. 1987-1997
|
artikel
|
| 20 |
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML
|
Choe, Sung
|
|
|
4 |
9 |
p. 1894-1905
|
artikel
|
| 21 |
Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series
|
Wise, Jillian F.
|
|
|
4 |
9 |
p. 1859-1866
|
artikel
|
| 22 |
Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease
|
Hsieh, Matthew M.
|
|
|
4 |
9 |
p. 2058-2063
|
artikel
|
| 23 |
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
|
Leppä, Sirpa
|
|
|
4 |
9 |
p. 1906-1915
|
artikel
|
| 24 |
Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome
|
Lee, Je-Hwan
|
|
|
4 |
9 |
p. 2032-2043
|
artikel
|
| 25 |
Poor tolerability to ponatinib in Indian CML patients
|
Singh, Charanpreet
|
|
|
4 |
9 |
p. 1927-1929
|
artikel
|
| 26 |
Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies
|
Ansell, Stephen M.
|
|
|
4 |
9 |
p. 1917-1926
|
artikel
|
| 27 |
Significance of antinuclear antibodies in primary immune thrombocytopenia: results of the CARMEN registry
|
Moulis, Guillaume
|
|
|
4 |
9 |
p. 1974-1977
|
artikel
|
| 28 |
Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases
|
Kahn, Justine M.
|
|
|
4 |
9 |
p. 2084-2094
|
artikel
|
| 29 |
Survival following allogeneic transplant in patients with myelofibrosis
|
Gowin, Krisstina
|
|
|
4 |
9 |
p. 1965-1973
|
artikel
|
| 30 |
Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis
|
Felber, Matthias
|
|
|
4 |
9 |
p. 1998-2010
|
artikel
|
| 31 |
The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL
|
Assouline, Sarit
|
|
|
4 |
9 |
p. 2011-2017
|
artikel
|
| 32 |
The sialyltransferase ST3Gal-IV guides murine T-cell progenitors to the thymus
|
Sitte, Selina
|
|
|
4 |
9 |
p. 1930-1941
|
artikel
|
| 33 |
Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease
|
Qi, Shunan
|
|
|
4 |
9 |
p. 2064-2072
|
artikel
|
Tijdschrift beschrijving